Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $600.08 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $234.75 | 7 | $0 (2024) |
| Stryker Corporation | $112.50 | 3 | $0 (2020) |
| GlaxoSmithKline, LLC. | $77.67 | 5 | $0 (2022) |
| GENZYME CORPORATION | $64.35 | 3 | $0 (2023) |
| PFIZER INC. | $45.03 | 2 | $0 (2022) |
| Intersect ENT, Inc. | $17.47 | 1 | $0 (2020) |
| Acclarent, Inc | $14.58 | 1 | $0 (2018) |
| Glenmark Therapeutics Inc. | $12.00 | 1 | $0 (2019) |
| Entellus Medical, Inc. | $10.87 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $10.86 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.37 | 1 | Optinose US, Inc. ($21.37) |
| 2023 | $29.19 | 1 | GENZYME CORPORATION ($29.19) |
| 2022 | $221.91 | 8 | OptiNose US, Inc. ($125.00) |
| 2021 | $42.79 | 2 | Optinose US, Inc. ($24.52) |
| 2020 | $89.41 | 3 | Stryker Corporation ($49.65) |
| 2019 | $159.10 | 7 | OptiNose US, Inc. ($63.86) |
| 2018 | $14.58 | 1 | Acclarent, Inc ($14.58) |
| 2017 | $21.73 | 2 | Entellus Medical, Inc. ($10.87) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/01/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Immunology | ||||||
| 11/10/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $109.37 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/10/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/28/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2022 | PFIZER INC. | GELFOAM (Device) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: HEMOSTAT | ||||||
| 04/01/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Immunology | ||||||
| 03/03/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/01/2020 | Stryker Corporation | ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM CONSUMABLES (Device), ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM | Food and Beverage | Cash or cash equivalent | $49.65 | General |
| Category: ENTELLUS | ||||||
| 03/10/2020 | PFIZER INC. | GELFOAM (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: HEMOSTAT | ||||||
| 02/25/2020 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/10/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/19/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2019 | Glenmark Therapeutics Inc. | Otiprio (Drug) | Food and Beverage | Cash or cash equivalent | $12.00 | General |
| Category: Antibiotic | ||||||
| 06/20/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/20/2019 | Stryker Corporation | ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.84 | General |
| Category: ENTELLUS | ||||||
| 05/15/2019 | Stryker Corporation | ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM CONSUMABLES (Device) | Food and Beverage | Cash or cash equivalent | $38.01 | General |
| Category: ENTELLUS | ||||||
| 04/30/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2018 | Acclarent, Inc | RELIEVA SCOUT Multi-Sinus Dilation System (Device), ACCLARENT SE INFLATION DEVICE, ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Rhinology | ||||||
| 10/16/2017 | Entellus Medical, Inc. | XprESS Multi-Sinus Dilation System (Device) | Food and Beverage | Cash or cash equivalent | $10.87 | General |
| Category: Otolaryngology | ||||||
| 04/24/2017 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 8,267 | 12,470 | $4.4M | $895,983 |
| 2022 | 30 | 7,579 | 10,993 | $3.1M | $799,810 |
| 2021 | 25 | 6,156 | 8,746 | $2.4M | $667,933 |
| 2020 | 24 | 5,384 | 7,360 | $1.9M | $481,410 |
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 642 | 1,338 | $990,120 | $226,946 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 692 | 1,472 | $609,620 | $165,628 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,014 | 1,968 | $569,280 | $152,023 | 26.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 875 | 1,481 | $382,910 | $51,126 | 13.4% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 1,103 | 1,305 | $314,775 | $51,005 | 16.2% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 1,185 | 1,475 | $438,710 | $47,106 | 10.7% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 233 | 343 | $167,650 | $40,558 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 184 | 184 | $108,205 | $27,836 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 248 | 248 | $98,200 | $23,946 | 24.4% |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | Office | 2023 | 268 | 285 | $175,285 | $21,466 | 12.2% |
| 92567 | Test to assess middle ear function | Office | 2023 | 1,149 | 1,432 | $175,420 | $20,933 | 11.9% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2023 | 48 | 84 | $83,160 | $15,757 | 18.9% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 228 | 369 | $60,555 | $9,924 | 16.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 56 | $31,440 | $9,077 | 28.9% |
| 69433 | Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | Office | 2023 | 23 | 28 | $29,435 | $5,486 | 18.6% |
| 69145 | Removal of growth in soft tissue of ear canal | Office | 2023 | 12 | 12 | $26,063 | $4,840 | 18.6% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 12 | 15 | $16,610 | $3,729 | 22.4% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2023 | 39 | 79 | $16,195 | $3,128 | 19.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 47 | 51 | $13,515 | $2,526 | 18.7% |
| 92584 | Test to assess electrical potentials generated in the inner ear as a result of sound stimulation | Office | 2023 | 22 | 24 | $11,955 | $2,435 | 20.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $9,790 | $2,304 | 23.5% |
| 69200 | Removal of foreign body in ear canal | Office | 2023 | 34 | 38 | $15,200 | $2,173 | 14.3% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 19 | 19 | $9,880 | $1,821 | 18.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 34 | $6,475 | $1,612 | 24.9% |
| 92517 | Vemp testing of lower branch of inner ear nerve with interpretation and report | Office | 2023 | 19 | 19 | $6,590 | $1,372 | 20.8% |
About Dr. Kenneth Scioscia, MD
Dr. Kenneth Scioscia, MD is a Otolaryngology healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023022712.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Scioscia, MD has received a total of $600.08 in payments from pharmaceutical and medical device companies, with $21.37 received in 2024. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($600.08).
As a Medicare-enrolled provider, Scioscia has provided services to 27,386 Medicare beneficiaries, totaling 39,569 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location New Hyde Park, NY
- Active Since 07/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1023022712
Products in Payments
- Xhance (Drug) $234.75
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM CONSUMABLES (Device) $87.66
- NUCALA (Biological) $77.67
- GELFOAM (Device) $45.03
- DUPIXENT (Biological) $43.96
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM (Device) $24.84
- DUPIXENT (Drug) $20.39
- PROPEL (Device) $17.47
- RELIEVA SCOUT Multi-Sinus Dilation System (Device) $14.58
- Otiprio (Drug) $12.00
- XprESS Multi-Sinus Dilation System (Device) $10.87
- DUPIXENT DUPILUMAB INJECTION (Biological) $10.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in New Hyde Park
Andrea Vambutas, Md, MD
Otolaryngology — Payments: $7,930
Ron Mitzner, M.d, M.D
Otolaryngology — Payments: $7,394
Mark Shikowitz, Md, MD
Otolaryngology — Payments: $5,291
Dr. Alexander Sorin, M.d, M.D
Otolaryngology — Payments: $3,348
Dr. William Karle, Md, MD
Otolaryngology — Payments: $2,105
Dr. Catherine Mae Geller, M.d, M.D
Otolaryngology — Payments: $229.93